-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Aligos Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2021 to Q4 2024.
- Aligos Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 6.26M shares, a 144% increase year-over-year.
- Aligos Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 6.26M shares, a 144% increase from 2023.
- Aligos Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 2.56M shares, a 94% decline from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)